Abstract
To assess whether fluoxetine and its metabolite, norfluoxetine, are inhibitors of the metabolism of CYP3A substrates. Because inhibition of the first-pass metabolism of terfenadine may be associated with fatal arrhythmia, we assessed the possibility that fluoxetine inhibits this metabolism as a model for CYP3A drug interactions. Male subjects (n = 12) were given two single doses of 60 mg terfenadine alone (treatment 1) and again after the eighth dose in a 9-day regimen of 60 mg fluoxetine once a day (treatment 2). Blood samples, collected up to 48 hours after each terfenadine dose, were assayed for terfenadine and terfenadine acid metabolite. The assay limits of quantification were 0.1 ng/ml and 5.0 ng/ml, respectively. Noncompartmental pharmacokinetic data for terfenadine and terfenadine acid metabolite were compared between treatments. Mean value +/- SD plasma concentrations of fluoxetine (165 +/- 45 ng/ml) and norfluoxetine (83 +/- 23 ng/ml) achieved after the eighth dose did not cause a significant change in terfenadine acid metabolite pharmacokinetics. All terfenadine concentrations were less than 5 ng/ml and they were approximately 30% lower after fluoxetine pretreatment compared with terfenadine alone. The area under the...Continue Reading
References
Nov 1, 1992·Clinical Pharmacology and Therapeutics·D J GreenblattJ S Harmatz
Mar 1, 1992·Clinical Pharmacology and Therapeutics·R F BergstromL Lemberger
Jan 1, 1992·Critical Reviews in Toxicology·S A Wrighton, J C Stevens
Sep 18, 1991·Journal of Chromatography·J E CoutantR A Okerholm
Jan 1, 1991·Journal of Pharmaceutical and Biomedical Analysis·T M ChenR A Okerholm
Jan 1, 1991·Psychopharmacology·T A LasherE J Antal
Dec 15, 1990·JAMA : the Journal of the American Medical Association·B P MonahanL R Cantilena
Nov 1, 1995·Clinical Pharmacology and Therapeutics·C Y WuV J Wacher
Jul 1, 1995·Clinical Pharmacology and Therapeutics·D Y GomezL Z Benet
Jun 1, 1994·Pharmaceutical Research·S A Wrighton, B J Ring
Dec 1, 1993·Journal of Clinical Pharmacology·P K HonigL R Cantilena
Jan 1, 1993·International Clinical Psychopharmacology·R F BergstromL Lemberger
Nov 1, 1993·The Annals of Pharmacotherapy·M P Swims
Mar 24, 1993·JAMA : the Journal of the American Medical Association·R L WoosleyR A Gillis
Sep 1, 1995·The Annals of Pharmacotherapy·R J MarchiandoS G Jue
Dec 15, 1995·Toxicology·A P LiA Rasmussen
Jan 1, 1996·Psychosomatics·T B StrouseF I Fawzy
Mar 1, 1996·Clinical Pharmacology and Therapeutics·B RobbinsJ Meligeni
Sep 1, 1996·Journal of Pharmaceutical and Biomedical Analysis·A XuJ Hulse
Dec 1, 1996·Journal of Clinical Pharmacology·M J GoldbergS Wrighton
Citations
Jan 4, 2001·Drug Metabolism Reviews·S A WrightonP B Watkins
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Emilio SternieriAnna Ferrari
Dec 24, 2011·Expert Opinion on Drug Metabolism & Toxicology·Alexandre ChanKevin Yi-Lwern Yap
Oct 22, 2004·Journal of Clinical Pharmacology·Samir GuptaJerry Herron
Dec 25, 2009·European Journal of Cancer Care·K Y-L YapA Chan
Jan 6, 2004·Fundamental & Clinical Pharmacology·Edoardo SpinaConcetta D'Arrigo
Oct 14, 2003·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M Murray, K Murray
Jun 22, 2002·Pharmacology & Toxicology·Thomas KerbuschJos H Beijnen
Jan 8, 2004·Journal of Clinical Psychopharmacology·C Lindsay DeVaneLauren Willard
Jun 14, 2006·Biopharmaceutics & Drug Disposition·Laurian VlaseMircea Nanulescu
Jul 19, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C Lindsay DeVane
Aug 5, 2000·Clinical Pharmacokinetics·E L Michalets, C R Williams
Oct 3, 1999·Journal of Clinical Psychopharmacology·M U Shad, S H Preskorn
Aug 10, 1999·Journal of Clinical Psychopharmacology·D J GreenblattR I Shader
Apr 11, 2001·Therapeutic Drug Monitoring·J LundmarkF Bengtsson
Jul 10, 2002·AAPS PharmSci·Carole LavigneAlain R Thierry
Sep 1, 2011·Clinical Drug Investigation·Laurian VlaseSorin E Leucuta
Sep 5, 2007·Drugs in R&D·Chen Chen
Dec 6, 2016·Current Pharmacology Reports·Barbara Wiśniowska, Sebastian Polak
Nov 10, 1998·Journal of Psychopharmacology·S H Preskorn
Mar 11, 2016·BMC Pharmacology & Toxicology·Barbara WiśniowskaSebastian Polak
Dec 25, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Lijing YanDilan Qin
Mar 14, 2018·Computational and Mathematical Methods in Medicine·Sebastian PolakJakub Szlęk